http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28339705

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 4591
issn 1178-6930
pageRange 4583-4591
publicationName OncoTargets and Therapy
startingPage 4583
bibliographicCitation Sun Y, Hou L, Yang Y, Xie H, Yang Y, Li Z, Zhao H, Gao W, Su B. Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma. Onco Targets Ther. 2016;9():4583–91. PMID: 27524912; PMCID: PMC4966694.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd242cd89ed3cd468c471dd425c8bd6f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1038c71853450c6cedffdb7d51a7dae3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2a2129ebc8b787c28ad81aadf409fae3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d5cb34c9d59bbdbfd280ebeabfab50c2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2dc7110372daaa56535d8b2dd20a44db
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9bbf436e4b376497652a92a2fd6dd638
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e14ee4027059749ae0003483d269943c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1797-8342
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d0398f6585fd42cf7620dd8b7014e72
date 201607
identifier https://pubmed.ncbi.nlm.nih.gov/PMC4966694
https://doi.org/10.2147/ott.s107272
https://pubmed.ncbi.nlm.nih.gov/27524912
isPartOf https://portal.issn.org/resource/ISSN/1178-6930
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37198
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15559608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11048
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_057f2386bb0d2f56aac3cfa6d26b7946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10509
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4f7df9ebc9d27b66bfc0e61339b19f48
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a08083d1fbea4c0660fb02a493fb196c
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6650
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b3050902014fc7ce927183681cc3a991
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442514
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_db7111fd5cd3f7aa8a2ceccace8d1a29
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_dc7f99c44cf1df2876c7e7bdcd024cc8
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID320930
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57953977
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_de34d6889522c73394d2abbf375aa5a1
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11049
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d7d07219eb0333b77b9c1ec30e7594d4
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_533622b82f51bc5431a771c088f3bdd9
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24180873
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6a90417ec6a66bf1b4d68f82b79834b3
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45029742

Total number of triples: 49.